Orally disintegrating tablet: formulation design and optimisation using Response Surface Methodology

Orally disintegrating tablet: formulation design and optimisation using Response Surface Methodology

The objective of this study was to develop diazepam orally disintegrating tablets and to optimize tablets characteristics using response surface methodology (RSM). Tablets were prepared by direct compression of mixture containing mannitol, copovidone, crosspovidone flavor and lubricant. A full fac...

Full description

Bibliographic Details
Main Authors:	Biljana Nestorovska-Gjosevska, Marija Glavas-Dodov, Katerina Goracinova
Format:	Article
Language:	English
Published:	University Ss Cyril and Methodius in Skopje, Faculty of Pharmacy and Macedonian Pharmaceutical Association 2005-12-01
Series:	Makedonsko Farmacevtski Bilten
Online Access:	http://bulletin.mfd.org.mk/volumes/Volume%2051/51_003.pdf

Similar Items

Formulation and evaluation of orally disintegrating clopidogrel tablets
by: Gamal Mohamed Mahrous, et al.

Design, formulation, and physicochemical evaluation of montelukast orally disintegrating tablet
by: Abolfazl Aslani, et al.
Published: (2016-01-01)

Formulation and in vitro Evaluations of Paracetamol Orally Disintegrating Tablets
by: Azmiera Azimuddin, et al.
Published: (2023-03-01)

Formulation and development of paediatric orally disintegrating carbamazepine tablets
by: R Canadell-Heredia, et al.
Published: (2022-11-01)

Pharmacokinetics and pharmacodynamics of an orally disintegrating tablet formulation of dexlansoprazole
by: Michael Kukulka, et al.
Published: (2016-11-01)

Predicting oral disintegrating tablet formulations by neural network techniques
by: Run Han, et al.
Published: (2018-07-01)

Natural Polymer Chitosan as Super Disintegrant in Fast Orally Disintegrating Meloxicam Tablets: Formulation and Evaluation
by: Gailute Draksiene, et al.
Published: (2021-06-01)

Recent Formulation Advances and Therapeutic Usefulness of Orally Disintegrating Tablets (ODTs)
by: Maimoona Chinwala
Published: (2020-10-01)

Formulation and evaluation of orally disintegrating tablet of Rizatriptan using natural superdisintegrant
by: Tabbakhian Majid, et al.
Published: (2014-01-01)

Formulation and evaluation of orally disintegrating tablet of ondansetron using natural superdisintegrant
by: Shahtalebi Mohammad Ali, et al.
Published: (2015-07-01)

Biopharmaceutical characterization of topical liposome formulations bearing 5-fluorouracil
by: Marija Glavas-Dodov, et al.
Published: (2003-08-01)

Application of Design of Experiment for development of orally disintegrating tablets
by: Irina Ermolina, et al.
Published: (2023-12-01)

Orally Disintegrating Tablet Formulation of Avicennia Fruit Ethanol Extract (Avicennia marina)
by: Ungsari Rizki Eka Purwanto, et al.
Published: (2021-12-01)

The Influence of Formulation and Manufacturing Process Parameters on the Characteristics of Lyophilized Orally Disintegrating Tablets
by: Marina Levina, et al.
Published: (2011-07-01)

A Potential Alternative Orodispersible Formulation to Prednisolone Sodium Phosphate Orally Disintegrating Tablets
by: Essam A. Tawfik, et al.
Published: (2021-01-01)

Midazolam-sirupus, formulation and pharmacodynamic efficacy
by: K. Goracinova, et al.
Published: (2002-04-01)

Effect of the buffer system on stability of tetracaine hydrochloride 0.5% eyedrops
by: Emilija Fredro-Kumbaradzi, et al.
Published: (2002-04-01)

Evaluation of preparation methods for orally disintegrating tablets
by: Yagmur Akdag, et al.
Published: (2020-03-01)

Development and Evaluation of Ondansetron Orally Disintegrating Tablets
by: Bipin Pustake, et al.
Published: (2019-12-01)

Development and evaluation of ofloxacin orally disintegrating tablets
by: Badrinath Pralhadrao Mohite, et al.
Published: (2012-06-01)

The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors
by: Nikola Geskovski, et al.
Published: (2021-04-01)

Tablets of soy protein-alginate microparticles with Lactobacillus casei 01: Physicochemical and biopharmaceutical properties
by: Hadzieva Jasmina, et al.
Published: (2019-01-01)

Pharmaceutical Evaluation of Levofloxacin Orally Disintegrating Tablet Formulation Using Low Frequency Raman Spectroscopy
by: Yoshihisa Yamamoto, et al.
Published: (2023-07-01)

Preparation and Evaluation of Directly Compressible Orally Disintegrating Tablets of Cannabidiol Formulated Using Liquisolid Technique
by: Ekapol Limpongsa, et al.
Published: (2022-11-01)

Development of an In Vitro Methodology to Assess the Bioequivalence of Orally Disintegrating Tablets Taken without Water
by: Toshihide Takagi, et al.
Published: (2023-08-01)

Enhancing the Low Oral Bioavailability of Sulpiride via Fast Orally Disintegrating Tablets: Formulation, Optimization and In Vivo Characterization
by: Hesham M. Tawfeek, et al.
Published: (2020-12-01)

Optimized furosemide taste masked orally disintegrating tablets
by: Mohamed Abbas Ibrahim, et al.
Published: (2017-11-01)

Effects of thickened drinks on the disintegration of various oral tablets
by: Taisuke Matsuo, et al.
Published: (2020-12-01)

Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
by: Chernet Tafere, et al.
Published: (2021-01-01)

A novel spray-dried nanoparticles-in-microparticles system for formulating scopolamine hydrobromide into orally disintegrating tablets
by: Li FQ, et al.
Published: (2011-04-01)

Formulation and Evaluation of Fast Disintegrating Tablets of Ondansetron Using Natural Superdisintegrants
by: Asha Maharjan, et al.
Published: (2023-08-01)

Captopril fast disintegrating tablets for children: formulation and quality control by HPLC
by: Shohreh Alipour, et al.
Published: (2017-09-01)

Captopril fast disintegrating tablets for children: formulation and quality control by HPLC
by: Shohreh Alipour, et al.
Published: (2017-09-01)

BSA - loaded gelatin microspheres: Comparative studies on biodegradation and drug release in presence of collagenase and trypsin
by: Kristina Mladenovska, et al.
Published: (2003-08-01)

The application prospects and development trends of orally disintegrating tablets to dogs
by: Tingting Yi

Development and evaluation of mosapride citrate orally disintegrating tablets for dogs
by: Tingting Yi

FORMULA OPTIMIZATION OF ORALLY DISINTEGRATING TABLET CONTAINING MELOXICAM NANOPARTICLES
by: Lina Winarti, et al.
Published: (2017-01-01)

A prediction model based on artificial intelligence techniques for disintegration time and hardness of fast disintegrating tablets in pre-formulation tests
by: Mehri Momeni, et al.
Published: (2024-03-01)

Development of α-Cyclodextrin-Based Orally Disintegrating Tablets for 4-Phenylbutyrate
by: Kindness L. Commey, et al.
Published: (2024-01-01)

Investigation of biopharmaceutical and physicochemical drug properties suitable for orally disintegrating tablets
by: Asami Ono, et al.
Published: (2016-12-01)